Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

Gillespie, who has been with the firm for over a decade, is a trusted expert in real estate transactions, specialising in ...

The K70 keyboard is one of Corsair's most iconic designs, and today the company has announced the latest entry to the series ...

Orlando police are set to enhance their crime-fighting capabilities with the introduction of drones ...

Today Mat is checking out the latest flagship gaming keyboard from Corsair. It's a low profile board, with Cherry Low Profile ...

The Boeing 737-800's value in 2026 is a stark contrast to its original price, revealing the aircraft's depreciation journey.

Wall Street analysts expect these artificial intelligence (AI) stocks to soar in the next year.

CEO Rick Smith noted the impact of AI and said Axon is at a "moment unlike anything" he has seen since starting the company.

By Anshuman Tripathy Feb 25 (Reuters) - Axon Enterprise shares jumped more than 19% in morning trading on Wednesday after the ...

Axon Enterprise (AXON) is transitioning from a SaaS+device vendor to a public-sector digital infrastructure provider, altering its financial profile and valuation dynamics. AXON's strong recurring ...

After months of infighting over Flock surveillance cameras in Denver, city leaders say Flock is on its way out and a ...

Axon shares surged after the Taser maker beat estimates for quarterly earnings and forecast faster-than-expected 2026 growth.